Summary:
A German university is offering innovative scientific results about new forms of infection treatment to medical, biotechnology and pharmaceutical industry for a license agreement. The pharmaceutical invention offers newly found compounds which inhibit and bond protozoa and bacteria by blocking the formate-nitrite transporter (FNT).
Description:
Pharmaceutical researchers from a university in North Germany found new compounds which direct against protozoa and bacteria. These compounds can be used as medication in the treatment of infections caused by protozoa and/or bacteria.
The invention relates to a process to inhibit, preferably destroy, protozoa and/or bacteria through bonding of protozoa and/or bacteria with at least one of the newly found compounds. The compounds are characterized by the fact that they block the Formate-Nitrite Transporter (FNT) of protozoa and bacteria.
In order to open up the market for this new way of infection treatment the university is offering its scientific results worldwide for a license agreement. They are looking for partners from the medical, pharmaceutical and biotechnology industry.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
The university is looking for partners from the medical, biotechnology and pharmaceutical industry to open up the market for this new way of infection medication. They offer their scientific results worldwide for a license agreement
Stage of Development:
Available for demonstration
IPR Status:
Patent(s) applied for but not yet granted
External code:
TODE20170609001
